跳至主要内容
临床试验/NCT01906463
NCT01906463已完成不适用

Social and Prognostic Inequalities in Patients Hospitalised for Cerebrovascular Accident (CVA) in Four Contrasting French Departments: Côte d'Or, Martinique, Guadeloupe and French Guyana Analysis of Their Impact on Vascular Risk Factors and the Management of CVA

Centre Hospitalier Universitaire Dijon1 个研究点 分布在 1 个国家目标入组 1,612 人开始时间: 2011年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,612
试验地点
1
主要终点
Medical history

研究概览

简要总结

This study should also raise questions about the interest and feasibility of establishing a permanent registry of CVA in the Antilles and Guyana. Indeed in coming decades, the expected doubling of the population of persons aged over 60 years and the foreseeable changes in lifestyle will increase the burden of this disease, in particular since the region is marked by a high prevalence of arterial hypertension and diabetes and a high level of precarity. In addition, this study will provide epidemiological information on CVA, its risk factors and management, which are non-existent for the department of French Guyana where the health environment is manifestly insufficient. These data should make it possible to better evaluate the resources available and the healthcare needs in Guyana.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Pre- inclusion
  • Patients who have received information about the study (directly or via a person of trust),
  • Patients aged more than 18 years,
  • Patient hospitalised for a suspected first symptomatic CVA (whatever the mechanism), preceded or not by a transient ischemic attack (TIA),
  • Patients with a cerebral imaging examination (CT-scan and/or MRI),
  • in Guyana, suspicion of a first CVA according to WHO clinical criteria and who died before the authorised images for descriptive purposes,
  • Patients able to answer questions personally or through a parent or a person of trust.
  • Definitive inclusion
  • Patients with confirmed CVA diagnosed according to clinical criteria (WHO criteria) and imaging criteria.

排除标准

  • - Patients who refuse to take part in the study,
  • Patients with prior symptomatic CVA,
  • Patients without cerebral imaging (except in Guyana, for patients with suspected CVA who died before imaging),
  • Patients with another severe evolutive disease that could cause death in the weeks following the CVA,
  • Patients who cannot be contacted by telephone at 1 month.

结局指标

主要结局

Medical history

时间窗: Baseline

次要结局

  • Follow-up questionnaire: functional handicap, intercurrent hospitalisation, vital status(Month 12)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验